Clinical Trials

Hyperfine starts enrolment in portable imaging workflow study

US-based health technology company Hyperfine has enrolled the first patient in the clinical workflow study of its US Food and Drug Administration (FDA)-approved portable...

CVRx has more data supporting long-term benefits of Barostim

CVRx announced the publication of post-market data highlighting long-term, sustained benefits with its Barostim device.Minneapolis-based CVRx published results from the BeAT-HF trial in the...

QT imaging’s breast imaging system proves as effective as mammography

Medical device company QT Imaging Holdings has announced positive data demonstrating that its Breast Acoustic CT scan imaging technique can be used as a...

Sight Sciences touts eye pressure reduction with glaucoma OMNI device

US-based Sight Sciences has published the two-year post-surgical outcomes of its minimally invasive glaucoma surgery device, the OMNI surgical system. The data from the real-world...

Signati kicks off trial investigating quicker vasectomy device

Signati Medical has enrolled the first patient in a clinical trial investigating its device designed to quicken vasectomy procedures. The trial, operating under an investigative...

Photopharmics kickstarts phototherapy trial for Parkinson’s disease 

US-based equipment manufacturer Photopharmics has announced the initiation of its ‘Celeste light for PD’ clinical trial investigating the Celeste phototherapy device.  The US Food and...

Novocure’s TTFields device slows metastasis in NSCLC

NovoCure’s Tumor Treating Fields (TTFields) therapy met its primary endpoint in the Phase III METIS trial by slowing the progression of brain metastasis in...

Cleerly touts new data for AI cardiovascular software

Digital healthcare company Cleerly has announced that positive data from two studies investigating its AI-QCT ISCHEMIA software device has been published.  Cleerly’s ISCHEMIA software device...

Nyxoah’s nerve stimulation device meets endpoints in sleep apnoea study

Nyxoah’s hypoglossal nerve stimulation system, Genio, met the co-primary endpoints at 12 months in the pivotal DREAM trial in adults with obstructive sleep apnoea...
1...202122...58Page 21 of 58

Latest articles